Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Patient navigation and clinical trial participation: A randomized controlled trial design.

Uveges MK, Lansey DG, Mbah O, Gray T, Sherden L, Wenzel J.

Contemp Clin Trials Commun. 2018 Sep 22;12:98-102. doi: 10.1016/j.conctc.2018.09.003. eCollection 2018 Dec.

2.

Increasing Physical Activity Amongst Overweight and Obese Cancer Survivors Using an Alexa-Based Intelligent Agent for Patient Coaching: Protocol for the Physical Activity by Technology Help (PATH) Trial.

Hassoon A, Schrack J, Naiman D, Lansey D, Baig Y, Stearns V, Celentano D, Martin S, Appel L.

JMIR Res Protoc. 2018 Feb 12;7(2):e27. doi: 10.2196/resprot.9096.

3.

Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials.

Eggly S, Hamel LM, Heath E, Manning MA, Albrecht TL, Barton E, Wojda M, Foster T, Carducci M, Lansey D, Wang T, Abdallah R, Abrahamian N, Kim S, Senft N, Penner LA.

BMC Cancer. 2017 Dec 2;17(1):807. doi: 10.1186/s12885-017-3804-5.

4.

The impact of insurance on access to cancer clinical trials at a comprehensive cancer center.

Klamerus JF, Bruinooge SS, Ye X, Klamerus ML, Damron D, Lansey D, Lowery JC, Diaz LA Jr, Ford JG, Kanarek N, Rudin CM.

Clin Cancer Res. 2010 Dec 15;16(24):5997-6003. doi: 10.1158/1078-0432.CCR-10-1451.

5.

Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors.

Messersmith WA, Jimeno A, Ettinger D, Laheru D, Brahmer J, Lansey D, Khan Y, Donehower RC, Elsayed Y, Zannikos P, Hidalgo M.

Cancer Chemother Pharmacol. 2008 Dec;63(1):181-8. doi: 10.1007/s00280-008-0733-7. Epub 2008 Apr 1.

Supplemental Content

Loading ...
Support Center